JP2006219454A5 - - Google Patents

Download PDF

Info

Publication number
JP2006219454A5
JP2006219454A5 JP2005036235A JP2005036235A JP2006219454A5 JP 2006219454 A5 JP2006219454 A5 JP 2006219454A5 JP 2005036235 A JP2005036235 A JP 2005036235A JP 2005036235 A JP2005036235 A JP 2005036235A JP 2006219454 A5 JP2006219454 A5 JP 2006219454A5
Authority
JP
Japan
Prior art keywords
agent according
therapeutic
prophylactic agent
dgla
skin disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005036235A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006219454A (ja
JP5546087B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from JP2005036235A external-priority patent/JP5546087B2/ja
Priority to JP2005036235A priority Critical patent/JP5546087B2/ja
Priority to EP19183855.6A priority patent/EP3581178B1/en
Priority to CA2599112A priority patent/CA2599112C/en
Priority to US11/884,199 priority patent/US9006287B2/en
Priority to EP06713928.7A priority patent/EP1852114B1/en
Priority to PCT/JP2006/302787 priority patent/WO2006085687A1/ja
Priority to CN2012100164426A priority patent/CN102600174A/zh
Priority to CN 200610003112 priority patent/CN101019853B/zh
Publication of JP2006219454A publication Critical patent/JP2006219454A/ja
Publication of JP2006219454A5 publication Critical patent/JP2006219454A5/ja
Publication of JP5546087B2 publication Critical patent/JP5546087B2/ja
Application granted granted Critical
Priority to US14/644,231 priority patent/US9943495B2/en
Priority to US15/911,806 priority patent/US10342773B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2005036235A 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤 Active JP5546087B2 (ja)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2005036235A JP5546087B2 (ja) 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤
EP19183855.6A EP3581178B1 (en) 2005-02-14 2006-02-10 Composition containing dihomo-(gamma)-linolenic acid (dgla) as active ingredient
CA2599112A CA2599112C (en) 2005-02-14 2006-02-10 Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient
US11/884,199 US9006287B2 (en) 2005-02-14 2006-02-10 Composition comprising dihomo-γ-linolenic acid (DGLA) as active ingredient
EP06713928.7A EP1852114B1 (en) 2005-02-14 2006-02-10 Composition containing dihomo-y-linolenic acid (dgla) as active ingredient
PCT/JP2006/302787 WO2006085687A1 (ja) 2005-02-14 2006-02-10 ジホモ−γ−リノレン酸（ＤＧＬＡ）を有効成分として含んで成る組成物
CN2012100164426A CN102600174A (zh) 2005-02-14 2006-02-14 含有有效成分二均-γ-亚麻酸(DGLA)的组成物
CN 200610003112 CN101019853B (zh) 2005-02-14 2006-02-14 含有有效成分二均-γ-亚麻酸(DGLA)的组成物
US14/644,231 US9943495B2 (en) 2005-02-14 2015-03-11 Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient
US15/911,806 US10342773B2 (en) 2005-02-14 2018-03-05 Composition containing dihomo-γ-linolenic acid (DGLA) as the active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005036235A JP5546087B2 (ja) 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012013311A Division JP2012082226A (ja) 2012-01-25 2012-01-25 皮膚疾患経口治療または予防剤

Publications (3)

Publication Number Publication Date
JP2006219454A JP2006219454A (ja) 2006-08-24
JP2006219454A5 true JP2006219454A5 (no) 2008-03-27
JP5546087B2 JP5546087B2 (ja) 2014-07-09

Family

ID=36981996

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005036235A Active JP5546087B2 (ja) 2005-02-14 2005-02-14 皮膚疾患経口治療または予防剤

Country Status (2)

Country Link
JP (1) JP5546087B2 (no)
CN (1) CN101019853B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006306813A (ja) * 2005-04-28 2006-11-09 Suntory Ltd 肥満細胞増殖抑制剤
JP2006306812A (ja) * 2005-04-28 2006-11-09 Suntory Ltd 好酸球浸潤抑制剤
US9006287B2 (en) 2005-02-14 2015-04-14 Suntory Holdings Limited Composition comprising dihomo-γ-linolenic acid (DGLA) as active ingredient
GB0907413D0 (en) * 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US9220702B2 (en) 2011-05-12 2015-12-29 Nippon Suisan Kaisha, Ltd. Composition for external use on skin for inflammatory diseases
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
US9855236B2 (en) 2011-10-19 2018-01-02 Ds Biopharma Limited Pharmaceutical compositions comprising DGLA and/or 15-HETrE and methods of use thereof
WO2013057287A1 (en) * 2011-10-19 2013-04-25 Dignity Sciences Limited Pharmaceutical compositions comprising dgla and/or 15-hetre and methods of use thereof
CA3134755A1 (en) 2013-12-04 2015-06-11 Nippon Suisan Kaisha, Ltd. Microbial biomass and microbial oils comprising dihomo-y linolenic acid from mortierella spp.
SG11201610207WA (en) 2014-06-04 2017-01-27 Dignity Sciences Ltd Pharmaceutical compositions comprising dgla and use of same
WO2017118911A1 (en) * 2016-01-07 2017-07-13 Dignity Sciences Limited Pharmaceutical compositions comprising dgla and use of same
EP3463332B1 (en) * 2016-06-01 2021-04-21 Société des Produits Nestlé S.A. Dgla in the prophylaxis of allergic disease
EP3624787A1 (en) * 2017-05-19 2020-03-25 DS Biopharma Limited Pharmaceutical compositions comprising dgla and use of same
EP4039326A4 (en) * 2019-10-01 2023-08-02 Suntory Holdings Limited COMPOSITION FOR IMPROVING INTESTINAL FUNCTION BY EXPRESSION CONTROL OF AQUAPORIN 3 AND ITS USE
CN118103039A (zh) * 2021-10-13 2024-05-28 花王株式会社 抗过敏剂
JP2023058457A (ja) * 2021-10-13 2023-04-25 花王株式会社 炎症性皮膚疾患の予防、治療又は改善剤
WO2023181755A1 (ja) * 2022-03-22 2023-09-28 東洋紡株式会社 皮膚機能関連因子に関する遺伝子の発現調節剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE47777B1 (en) * 1978-01-23 1984-06-13 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
GB8806737D0 (en) * 1988-03-22 1988-04-20 Efamol Holdings Therapeutic composition & method
JP2002047176A (ja) * 2000-08-04 2002-02-12 Idemitsu Technofine Co Ltd ＩｇＥ産生抑制剤

Similar Documents

Publication Publication Date Title
JP2006219454A5 (no)
CA2549103C (en) Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof
US6630157B1 (en) Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides
US9687462B2 (en) Sn-2-monoacylglycerols and lipid malabsorption
JP2007523049A5 (no)
NZ600740A (en) Compositions containing pufa and/or uridine and methods of use thereof
WO2009091538A8 (en) Pharmaceutical composition comprising epa and dha for treating hypertriglyceridemia and hypercholesterolemia
SG10201400685SA (en) Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia
SI2443246T1 (en) Compounds and procedures for lowering triglycerides without increasing the levels of LDL-C in an individual who is simultaneously receiving statin therapy
NZ627238A (en) Stable pharmaceutical composition comprising ethyl eicosapentaenoate
NO20076382L (no) Anvendelse av dokosaheksaenglyserider i behandlingen av tumorese sykdommer
JP2021508321A (ja) 睡眠及び気分障害の治療及び／又は改善における使用のための組成物
JP2006306813A5 (no)
JP2006306812A5 (no)
AU2014343898A1 (en) Monoacylglycerols for use in the treatment of malabsorption having a mechanical basis
RU2771277C2 (ru) Лечение травматического повреждения головного мозга
TW201110995A (en) Oral composition for alleviation of ultraviolet radiation-induced damage
CN117202796A (zh) 用于在肠道中治疗性生成丁酸的三丁酸甘油酯的口服剂量组合物
JP2007326799A5 (no)
JP2005524629A5 (no)
JP2009539968A (ja) メラトニン成分及びオメガ−３−脂肪酸成分を含む組成物及びキット
JP5759663B2 (ja) 皮膚バリア機能改善剤等
JP2012077022A (ja) Ｉｌ−８発現抑制組成物
US20160263072A1 (en) Monoacylglycerols and fat-soluble nutrients for use in the treatment of malabsorption having a non-mechanical basis
CA2427289A1 (en) Fat composition and hexacosanoic acid depressant for oral or enteral administration